Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Inhibitors (4)

Isotope-Labeled Compounds Related Products (9980):

Cat. No.	Product Name	Effect	Purity	Chemical Structure

HY-W700136

N-(4-(Benzyloxy)-3-(methylthio)phenyl)acetamide-d₃
N-(4-(Benzyloxy)-3-(methylthio)phenyl)acetamide-d₃ is the deuterium labeled N-(4-(Benzyloxy)-3-(methylthio)phenyl)acetamide (HY-W699901).

HY-133707S

β-Muricholic acid-d₅
β-Muricholic acid-d₅ is the deuterium labeled β-Muricholic acid.

HY-W768990

Vinclozolin-¹³C₃,d₃
Vinclozolin-¹³C₃,d₃ is the deuterium and ¹³C-labeled Vinclozolin (HY-B2061).

HY-W101563S

Propan-2-amine-d₆ hydrochloride		98.43%
Propan-2-amine-d₆ hydrochloride is the deuterium labeled Propan-2-amine.

HY-W178868S

Lodoxamide impurity 1-d₅
Lodoxamide impurity 1-d₅ is deuterium labeled n-Ethyl-2-hydroxyacetamide.

HY-W700648

Zolpidem phenyl-4-carboxylic acid-d₆
Zolpidem phenyl-4-carboxylic acid-d₆ is the deuterium labeled 4-(3-(2-(Dimethylamino)-2-oxoethyl)-6-methylimidazo[1,2-a]pyridin-2-yl)benzoic acid (HY-W700647).

HY-W699813

3β-Ursodeoxycholic acid-d₅
3β-Ursodeoxycholic acid-d₅ (Isoursodeoxycholic acid-d₅) is the deuterium labeled 3β-Ursodeoxycholic acid.

HY-B1886S

Chlorocholine-d₄ chloride
Chlorocholine-d₄ (chloride) is the deuterium labeled Chlorocholine chloride.

HY-12751S

Trimethobenzamide-d₆
Trimethobenzamide-d₆ is deuterium labeled Trimethobenzamide. Trimethobenzamide is a blocker of the D2 receptor. Trimethobenzamide is an antiemetic used to prevent nausea and vomiting.

HY-12296S

Navtemadlin-d₇
Navtemadlin-d₇ is the deuterium labeled Navtemadlin. Navtemadlin (AMG 232) is a potent, selective and orally available inhibitor of p53-MDM2 interaction, with an IC₅₀ of 0.6 nM. Navtemadlin binds to MDM2 with a Kd of 0.045 nM.

HY-W778990

2-Deoxyuridine-1,2,3,4,5-¹³C₅
2-Deoxyuridine-1,2,3,4,5-¹³C₅ is the ¹³C-labeled 2'-Deoxyuridine (HY-D0186). 2’-deoxyuridine is a brain-penetrant pyrimidines nucleotide that is associated with nervous system diseases. 2'-Deoxyuridine could increase chromosome breakage and results in a decreased thymidylate synthetase activity. 2'-Deoxyuridine is a precursor in the synthesis of Edoxudine (HY-B1011) and also an analogue of 5-ethynyl-2'-deoxyuridine, EdU (HY-118411). 2’-deoxyuridine reduces microglial activation and improve oxidative stress damage by modulating glycolytic metabolism on the Aβ25-35-induced brain injury, which is promising for research of Alzheimer’s disease (AD).

HY-W015824S3

DL-Aspartic acid-¹³C₁
DL-Aspartic acid-¹³C₁ is the ¹³C labeled DL-Aspartic acid.

HY-17507S1

Pantoprazole-d₃
Pantoprazole-d₃ is deuterium labeled Pantoprazole. Pantoprazole (BY10232) is an orally active and potent proton pump inhibitor (PPI). Pantoprazole, a substituted benzimidazole, is a potent H+/K+-ATPase inhibitor with an IC₅₀ of 6.8 μM. Pantoprazole improves pH stability and has anti-secretory, anti-ulcer activities. Pantoprazole significantly increased tumor growth delay combined with Doxorubicin (HY-15142).

HY-144561S

6α,3'-p-Dihydroxy paclitaxel-d₅
6α,3'-p-Dihydroxy paclitaxel-d₅ is the deuterium labeled 6α,3′-p-Dihydroxypaclitaxel (HY-N11628).

HY-143926S

Methyl Belinostat-d₅
Methyl Belinostat-d₅ is the deuterium labeled Methyl Belinostat.

HY-158254S

(Rac)-Trandolaprilate-d₅
rac-Trandolaprilat-d₅ is deuterium labeled rac-Trandolaprilat.

HY-143059S1

N-Trityl olmesartan ethyl ester-d₆
N-Trityl olmesartan ethyl ester-d₆ is the deuterium labeled Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate (HY-W416485).

HY-10201S4

Sorafenib-d₃ tosylate
Sorafenib-d₃ (Donafenib-d₃) tosylate is the deuterium labeled Sorafenib (HY-10201). Sorafenib is a potent and orally active Raf inhibitor with IC50s of 6 nM and 20 nM for Raf-1 and B-Raf, respectively. Sorafenib-d3tosylate is a multikinase inhibitor with IC50s of 90 nM, 15 nM, 20 nM, 57 nM and 58 nM for VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit, respectively. Sorafenib-d3tosylate induces autophagy and apoptosis. Sorafenib-d3tosylate has anti-tumor activity. Sorafenib is a ferroptosis activator.

HY-B0932S1

Levocarnitine propionate-d₅ hydrochloride
Levocarnitine propionate-d₅ (hydrochloride) is the deuterium labeled Levocarnitine propionate hydrochloride. Levocarnitine propionate hydrochloride (L-Propionylcarnitine chloride; ST-261) is used to treat the deterioration of renal function, congestive heart failure, intermittent claudication, and other diseases.

HY-121272AS2

Difloxacin-d₃		98.0%
Difloxacin-d₃ is the deuterium labeled Difloxacin.

Name
Email *

	Sorry, but the email address you supplied was invalid.